NEW YORK -- The American biotechnology company Novavax announced on Monday that its coronavirus vaccine candidate was found to have an overall efficacy of 90.4% in a Phase 3 trial conducted across the ...

Key opportunities in the COVID-19 market include the development of combination vaccines, innovative delivery methods like nasal sprays and oral pills, and new drug classes such as oral galectin ...

ETHealthworld.com brings latest bharat biotech news, views and updates from all top sources for the Indian Health industry.

The vaccine won't be immediately available, as it still needs to be reviewed by the US Food and Drug Administration.

Mast interviewed more than two dozen former and current Moderna employees, along with analysts, rival executives, investors, and experts in mRNA and vaccines to understand how the company arrived at ...

The Fight of Our Lives highlights biotech’s impact on patient lives in both the short- and long-term, urging continued ...

U.S. regulators approved updated COVID-19 shots Wednesday but limited their use for many Americans - and removed one of the two vaccines available for young children. OSPRI is a union of three ...

Anbio Biotechnology NNNN reported full-year 2025 results on Tuesday, with sales rising to $8.65 million from $8.19 million in ...

Headwinds in the sector are clearing. That is good news for venture firms seeking liquidity and for a stock market looking for growth stories, Nilesh Kumar writes in a guest commentary.

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...